Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY23 earnings guidance on Thursday. The company provided EPS guidance of $3.10-3.18 for the period, compared to the consensus EPS estimate of $3.13. The company issued revenue guidance of $1.55-1.56 billion, compared to the consensus revenue estimate of $1.56 billion. Integra LifeSciences also updated its FY […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided EPS guidance of $3.10-$3.18 for the period, compared to the consensus EPS estimate of $3.12. The company issued revenue guidance of $1.55 billion-$1.56 billion, compared to the consensus revenue estimate of $1.56 billion. Integra LifeSciences also updated […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) issued an update on its third quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.76-0.80 for the period, compared to the consensus earnings per share estimate of $0.83. The company issued revenue guidance of $386-390 million, compared to the consensus revenue estimate […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY23 earnings guidance on Thursday. The company provided EPS guidance of $3.10-3.18 for the period, compared to the consensus EPS estimate of $3.13. The company issued revenue guidance of $1.55-1.56 billion, compared to the consensus revenue estimate of $1.56 billion. Integra LifeSciences also updated its FY […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) announced its earnings results on Wednesday. The life sciences company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.14, Briefing.com reports. The business had revenue of $381.30 million for the quarter, compared to analysts’ expectations of $388.79 million. Integra LifeSciences […]